Product image of Medikinet Xl (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet Xl

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet Xl (Methylphenidate Hydrochloride)

Methylphenidate Hydrochloride, the active ingredient in Medikinet XL, is a central nervous system stimulant presented as an extended‑release tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents and adults by enhancing focus and reducing excessive daytime sleepiness.

GNH India supplies Medikinet XL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support efficient global distribution across markets worldwide.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medikinet XL, containing methylphenidate, is used in central nervous system stimulant therapy for neurodevelopmental and sleep‑wake disorders.

  • Attention deficit hyperactivity disorder: Improves concentration, reduces hyperactivity and impulsivity in patients.
  • Narcolepsy: Decreases daytime sleepiness and enhances wakefulness.

How It Works

  • Methylphenidate hydrochloride blocks the reuptake of dopamine and norepinephrine at presynaptic neuronal membranes, increasing their extracellular concentrations. The elevated catecholamine levels enhance neurotransmission in brain regions that regulate attention, impulse control, and arousal, thereby improving focus and reducing excessive sleepiness.

Side Effects

Methylphenidate may cause a range of adverse reactions, from mild to serious. Patients should be aware of common experiences and rare but potentially severe events.

Common Side Effects

  • Insomnia: Difficulty falling or staying asleep.
  • Decreased appetite: Reduced hunger leading to weight loss.
  • Headache: Mild to moderate cranial pain.
  • Stomach pain: Gastrointestinal discomfort.
  • Irritability: Mood changes and increased agitation.
  • Increased heart rate: Mild tachycardia.

Serious or Rare Side Effects

  • Hypertension: Elevated blood pressure requiring medical attention.
  • Cardiac arrhythmia: Abnormal heart rhythms that may be life‑threatening.
  • Psychosis: Hallucinations or delusional thinking.
  • Seizures: New onset or worsening of seizure activity.
  • Severe allergic reaction: Rash, swelling, or anaphylaxis.
  • Visual disturbances: Blurred vision or other eye problems.

Precautions & Warnings

Before prescribing Medikinet XL, clinicians should evaluate several safety considerations.

  • Cardiovascular assessment: Review patient history of heart disease, hypertension, or arrhythmias.
  • Psychiatric monitoring: Observe for new or worsening anxiety, depression, or psychotic symptoms.
  • Growth monitoring: Track height and weight regularly in pediatric patients.
  • Abuse potential: Use only as prescribed; avoid sharing or misuse.
  • Concomitant MAO inhibitors: Discontinue MAO inhibitors at least 14 days before starting therapy.
  • Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Avoid Interactions

Methylphenidate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): Risk of hypertensive crisis.
  • Tricyclic antidepressants: May increase cardiovascular side effects.
  • Antihypertensive agents: May reduce blood‑pressure control.

Moderate Interactions (Monitor Closely)

  • CYP2D6 inhibitors (e.g., fluoxetine): May raise methylphenidate concentrations.
  • Alcohol: May enhance central nervous system stimulation.

Frequently Asked Questions

Medikinet XL is prescribed to manage attention deficit hyperactivity disorder (ADHD) and narcolepsy. In ADHD, it helps improve focus, reduce hyperactivity, and control impulsive behavior. For narcolepsy, it lessens excessive daytime sleepiness and supports wakefulness, allowing patients to maintain a more normal daily routine.

Methylphenidate blocks the reuptake of dopamine and norepinephrine, two key neurotransmitters, at neuronal synapses. By preventing their removal, it raises their levels in the brain, which enhances signaling pathways involved in attention, executive function, and arousal, thereby producing the therapeutic effects seen in ADHD and narcolepsy.

The dosage of Medikinet XL is individualized and set by a qualified prescriber based on the patient’s age, clinical response, and tolerability. Physicians start with a low dose and may adjust it gradually, following clinical guidelines and monitoring for effectiveness and side effects.

Safety data for methylphenidate in pregnancy and lactation are limited. Healthcare providers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss their situation with a physician before using Medikinet XL.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Medikinet XL is an extended‑release formulation of methylphenidate, offering once‑daily dosing and a smooth plasma concentration curve. Compared with immediate‑release stimulants, it may provide more consistent symptom control and fewer peaks and troughs. Non‑stimulant options such as atomoxetine work via different mechanisms and have distinct side‑effect profiles.

Store Medikinet XL tablets at ambient temperature, below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging is tightly closed to maintain stability throughout its shelf life.

Medikinet XL is taken orally, usually in the morning with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole; it must not be split, chewed, or crushed, to preserve the extended‑release properties.

Serious risks include cardiovascular events such as hypertension, arrhythmias, and rare cases of myocardial infarction. Neuropsychiatric concerns involve the emergence of psychosis, severe anxiety, or suicidal thoughts. Additionally, there is a potential for misuse or dependence, so careful monitoring is essential.

Medikinet XL is contraindicated in individuals with known hypersensitivity to methylphenidate or any tablet components, those taking monoamine oxidase inhibitors (MAOIs) within the past 14 days, and patients with severe cardiovascular disorders, uncontrolled hypertension, or a history of serious psychiatric conditions without appropriate supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT